Clinical Trial Update: PCV10 Immunogenicity Study Nepal 2015 [Phase 4]

View source ↗

Summary

Phase 4 immunogenicity study of PCV10 conducted in Nepal has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcus Pneumoniae

Drugs mentioned

• PCV10 (pneumococcal 10-valent conjugate vaccine)

Snippet

Sponsor: University of Oxford | Conditions: Streptococcus Pneumoniae | Phase 4 | Status: COMPLETED